Cargando…
Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
BACKGROUND: The infertility caused by polycystic ovary syndrome (PCOS) has received considerable attention. Considerable efforts have been made to improve the rates of pregnancy and live birth. Cangfu Daotan Decoction (CFDTD) is a classic prescription for treating infertility in obese women. The eff...
Autores principales: | Wu, Linling, Zhang, Han, Fan, Mengxiao, Yan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129968/ https://www.ncbi.nlm.nih.gov/pubmed/35620410 http://dx.doi.org/10.1155/2022/4395612 |
Ejemplares similares
-
Cangfu daotan decoction for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Park, Hye-Rin, et al.
Publicado: (2019) -
Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-κB/LCN-2 signaling pathway in inflammatory microenvironment
por: Liu, Shuowen, et al.
Publicado: (2022) -
Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis
por: Li, Yuan, et al.
Publicado: (2023) -
Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology
por: Xu, Wenting, et al.
Publicado: (2020) -
Mechanism of Xiaoying Daotan decoction in treating Hashimoto’s thyroiditis based on the Notch/Treg/Th17 pathway
por: Zhou, Yingjia, et al.
Publicado: (2021)